Interventional Consumable - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241526

Publication Date:

October 1, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The consumable used in interventional survey.
The global market for Interventional Consumable was estimated to be worth US$ 845 million in 2023 and is forecast to a readjusted size of US$ 1367.9 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Interventional Consumable, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Interventional Consumable by region & country, by Type, and by Application.
The Interventional Consumable market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Consumable.
麻豆原创 Segmentation
By Company
Abbott
Philips
Boston Scientific
Medtronic
Edwards Lifesciences
Terumo
Nipro
B. Braun
MicroPort Medical
Lepu Medical
JWMS
Segment by Type:
Stent
Catheter
Guide Wires
Other
Segment by Application
Hospital
Cardiac Cath Lab
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Interventional Consumable manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Interventional Consumable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Interventional Consumable in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Interventional Consumable Product Introduction
1.2 Global Interventional Consumable 麻豆原创 Size Forecast
1.3 Interventional Consumable 麻豆原创 Trends & Drivers
1.3.1 Interventional Consumable Industry Trends
1.3.2 Interventional Consumable 麻豆原创 Drivers & Opportunity
1.3.3 Interventional Consumable 麻豆原创 Challenges
1.3.4 Interventional Consumable 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Interventional Consumable Players Revenue Ranking (2023)
2.2 Global Interventional Consumable Revenue by Company (2019-2024)
2.3 Key Companies Interventional Consumable Manufacturing Base Distribution and Headquarters
2.4 Key Companies Interventional Consumable Product Offered
2.5 Key Companies Time to Begin Mass Production of Interventional Consumable
2.6 Interventional Consumable 麻豆原创 Competitive Analysis
2.6.1 Interventional Consumable 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Interventional Consumable Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Consumable as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stent
3.1.2 Catheter
3.1.3 Guide Wires
3.1.4 Other
3.2 Global Interventional Consumable Sales Value by Type
3.2.1 Global Interventional Consumable Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Interventional Consumable Sales Value, by Type (2019-2030)
3.2.3 Global Interventional Consumable Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Cardiac Cath Lab
4.1.3 Other
4.2 Global Interventional Consumable Sales Value by Application
4.2.1 Global Interventional Consumable Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Interventional Consumable Sales Value, by Application (2019-2030)
4.2.3 Global Interventional Consumable Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Interventional Consumable Sales Value by Region
5.1.1 Global Interventional Consumable Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Interventional Consumable Sales Value by Region (2019-2024)
5.1.3 Global Interventional Consumable Sales Value by Region (2025-2030)
5.1.4 Global Interventional Consumable Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Interventional Consumable Sales Value, 2019-2030
5.2.2 North America Interventional Consumable Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Interventional Consumable Sales Value, 2019-2030
5.3.2 Europe Interventional Consumable Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Interventional Consumable Sales Value, 2019-2030
5.4.2 Asia Pacific Interventional Consumable Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Interventional Consumable Sales Value, 2019-2030
5.5.2 South America Interventional Consumable Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Interventional Consumable Sales Value, 2019-2030
5.6.2 Middle East & Africa Interventional Consumable Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Interventional Consumable Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Interventional Consumable Sales Value
6.3 United States
6.3.1 United States Interventional Consumable Sales Value, 2019-2030
6.3.2 United States Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Interventional Consumable Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Interventional Consumable Sales Value, 2019-2030
6.4.2 Europe Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Interventional Consumable Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Interventional Consumable Sales Value, 2019-2030
6.5.2 China Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.5.3 China Interventional Consumable Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Interventional Consumable Sales Value, 2019-2030
6.6.2 Japan Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Interventional Consumable Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Interventional Consumable Sales Value, 2019-2030
6.7.2 South Korea Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Interventional Consumable Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Interventional Consumable Sales Value, 2019-2030
6.8.2 Southeast Asia Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Interventional Consumable Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Interventional Consumable Sales Value, 2019-2030
6.9.2 India Interventional Consumable Sales Value by Type (%), 2023 VS 2030
6.9.3 India Interventional Consumable Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Interventional Consumable Products, Services and Solutions
7.1.4 Abbott Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Recent Developments
7.2 Philips
7.2.1 Philips Profile
7.2.2 Philips Main Business
7.2.3 Philips Interventional Consumable Products, Services and Solutions
7.2.4 Philips Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.2.5 Philips Recent Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Profile
7.3.2 Boston Scientific Main Business
7.3.3 Boston Scientific Interventional Consumable Products, Services and Solutions
7.3.4 Boston Scientific Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.3.5 Medtronic Recent Developments
7.4 Medtronic
7.4.1 Medtronic Profile
7.4.2 Medtronic Main Business
7.4.3 Medtronic Interventional Consumable Products, Services and Solutions
7.4.4 Medtronic Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.4.5 Medtronic Recent Developments
7.5 Edwards Lifesciences
7.5.1 Edwards Lifesciences Profile
7.5.2 Edwards Lifesciences Main Business
7.5.3 Edwards Lifesciences Interventional Consumable Products, Services and Solutions
7.5.4 Edwards Lifesciences Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.5.5 Edwards Lifesciences Recent Developments
7.6 Terumo
7.6.1 Terumo Profile
7.6.2 Terumo Main Business
7.6.3 Terumo Interventional Consumable Products, Services and Solutions
7.6.4 Terumo Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.6.5 Terumo Recent Developments
7.7 Nipro
7.7.1 Nipro Profile
7.7.2 Nipro Main Business
7.7.3 Nipro Interventional Consumable Products, Services and Solutions
7.7.4 Nipro Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.7.5 Nipro Recent Developments
7.8 B. Braun
7.8.1 B. Braun Profile
7.8.2 B. Braun Main Business
7.8.3 B. Braun Interventional Consumable Products, Services and Solutions
7.8.4 B. Braun Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.8.5 B. Braun Recent Developments
7.9 MicroPort Medical
7.9.1 MicroPort Medical Profile
7.9.2 MicroPort Medical Main Business
7.9.3 MicroPort Medical Interventional Consumable Products, Services and Solutions
7.9.4 MicroPort Medical Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.9.5 MicroPort Medical Recent Developments
7.10 Lepu Medical
7.10.1 Lepu Medical Profile
7.10.2 Lepu Medical Main Business
7.10.3 Lepu Medical Interventional Consumable Products, Services and Solutions
7.10.4 Lepu Medical Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.10.5 Lepu Medical Recent Developments
7.11 JWMS
7.11.1 JWMS Profile
7.11.2 JWMS Main Business
7.11.3 JWMS Interventional Consumable Products, Services and Solutions
7.11.4 JWMS Interventional Consumable Revenue (US$ Million) & (2019-2024)
7.11.5 JWMS Recent Developments
8 Industry Chain Analysis
8.1 Interventional Consumable Industrial Chain
8.2 Interventional Consumable Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Interventional Consumable Sales Model
8.5.2 Sales Channel
8.5.3 Interventional Consumable Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott
Philips
Boston Scientific
Medtronic
Edwards Lifesciences
Terumo
Nipro
B. Braun
MicroPort Medical
Lepu Medical
JWMS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.